文献速递性腺与生殖内分泌

中枢性性早熟女孩中MECP2基因的罕见变异:一项转化队列研究

Rare variants in the MECP2 gene in girls with central precocious puberty: a translational cohort study.
PubMed 文献 · Lancet Diabetes Endocrinol · 2023-06-26

这项转化队列研究招募了来自五个国家七个三级中心的404例特发性中枢性性早熟患者,通过高通量测序和Sanger测序检测MECP2基因的罕见变异,在5名女孩中发现了3种罕见杂合可能致病的编码变异,并在小鼠中证实Mecp2蛋白与GnRH神经元共定位。作者认为MECP2可能参与人类青春期启动的下丘脑调控。

要点

  • 在404例特发性中枢性性早熟患者中,5名女孩携带MECP2罕见可能致病编码变异,均无Rett综合征表现。
  • 鉴定出三种罕见杂合可能致病编码变异:Arg97Cys(同卵双胎姐妹)、Ser176Arg(1例)和Ala6_Ala8dup(2例无关女孩)。
  • 另在2例无关女孩中鉴定出一种罕见杂合3'UTR MECP2插入(36_37insT)。

核心结论

  • 在 girls with central precocious puberty 中鉴定出罕见MECP2变异,伴或不伴轻度神经发育异常。
  • MECP2可能在下丘脑调控人类青春期启动中起作用,为表观遗传和遗传机制参与这一关键生物学过程增添了证据。

研究设计与样本

  • 转化队列研究,参与者来自五个国家(巴西、西班牙、法国、美国和英国)的七个三级中心。
  • 纳入标准为女孩8岁前、男孩9岁前出现进行性青春期体征(Tanner 2期)且基础或GnRH兴奋后LH达青春期浓度;排除外周性性早熟及已知中枢性性早熟病因。
  • 共纳入404例特发性中枢性性早熟患者(383例[95%]女孩和21例[5%]男孩;261例[65%]散发和143例[35%]家族性,来自134个无关家系)。
  • 对133例患者行高通量测序,另对271例患者行MECP2的Sanger测序;并在小鼠中检测Mecp2在下丘脑的表达及其与GnRH神经元的共定位。

主要发现

  • 在5名女孩中鉴定出三种罕见杂合可能致病的编码变异:两名同卵双胎姐妹携带de novo错义变异Arg97Cys并伴有小头畸形;一名散发中枢性性早熟、肥胖和孤独症女孩携带de novo错义变异Ser176Arg;两名无关散发中枢性性早熟女孩携带插入变异Ala6_Ala8dup。
  • 另在两名无关散发中枢性性早熟女孩中鉴定出一种罕见杂合3'UTR MECP2插入(36_37insT)。
  • 上述携带MECP2变异的女孩均未表现出Rett综合征。
  • 小鼠中Mecp2蛋白与GnRH表达在负责GnRH调控的下丘脑核团中共定位。

关键数值与推荐

  • 共404例特发性中枢性性早熟患者纳入分析,其中女孩383例(95%),男孩21例(5%)。
  • 散发病例261例(65%),家族性病例143例(35%),来自134个无关家系。
  • 在5名女孩中鉴定出三种罕见杂合可能致病编码变异,另在2名女孩中鉴定出一种罕见杂合3'UTR插入。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Identification of genetic causes of central precocious puberty have revealed epigenetic mechanisms as regulators of human pubertal timing. MECP2, an X-linked gene, encodes a chromatin-associated protein with a role in gene transcription. MECP2 loss-of-function mutations usually cause Rett syndrome, a severe neurodevelopmental disorder. Early pubertal development has been shown in several patients with Rett syndrome. The aim of this study was to explore whether MECP2 variants are associated with an idiopathic central precocious puberty phenotype. METHODS: In this translational cohort study, participants were recruited from seven tertiary centres from five countries (Brazil, Spain, France, the USA, and the UK). Patients with idiopathic central precocious puberty were investigated for rare potentially damaging variants in the MECP2 gene, to assess whether MECP2 might contribute to the cause of central precocious puberty. Inclusion criteria were the development of progressive pubertal signs (Tanner stage 2) before the age of 8 years in girls and 9 years in boys and basal or GnRH-stimulated LH pubertal concentrations. Exclusion criteria were the diagnosis of peripheral precocious puberty and the presence of any recognised cause of central precocious puberty (CNS lesions, known monogenic causes, genetic syndromes, or early exposure to sex steroids). All patients included were followed up at the outpatient clinics of participating academic centres. We used high-throughput sequencing in 133 patients and Sanger sequencing of MECP2 in an additional 271 patients. Hypothalamic expression of Mecp2 and colocalisation with GnRH neurons were determined in mice to show expression of Mecp2 in key nuclei related to pubertal timing regulation. FINDINGS: Between Jun 15, 2020, and Jun 15, 2022, 404 patients with idiopathic central precocious puberty (383 [95%] girls and 21 [5%] boys; 261 [65%] sporadic cases and 143 [35%] familial cases from 134 unrelated families) were enrolled and assessed. We identified three rare heterozygous likely damaging coding variants in MECP2 in five girls: a de novo missense variant (Arg97Cys) in two monozygotic twin sisters with central precocious puberty and microcephaly; a de novo missense variant (Ser176Arg) in one girl with sporadic central precocious puberty, obesity, and autism; and an insertion (Ala6_Ala8dup) in two unrelated girls with sporadic central precocious puberty. Additionally, we identified one rare heterozygous 3'UTR MECP2 insertion (36_37insT) in two unrelated girls with sporadic central precocious puberty. None of them manifested Rett syndrome. Mecp2 protein colocalised with GnRH expression in hypothalamic nuclei responsible for GnRH regulation in mice. INTERPRETATION: We identified rare MECP2 variants in girls with central precocious puberty, with or without mild neurodevelopmental abnormalities. MECP2 might have a role in the hypothalamic control of human pubertal timing, adding to the evidence of involvement of epigenetic and genetic mechanisms in this crucial biological process. FUNDING: Fundação de Amparo à Pesquisa do Estado de São Paulo, Conselho Nacional de Desenvolvimento Científico e Tecnológico, and the Wellcome Trust.

来源:Lancet Diabetes Endocrinol,查看原文。版权归原作者所有。

引用

  1. Canton APM, Tinano FR, Guasti L, et al. Rare variants in the MECP2 gene in girls with central precocious puberty: a translational cohort study. Lancet Diabetes Endocrinol. 2023. PMID: 37385287. doi:10.1016/S2213-8587(23)00131-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。